C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
11/2003
11/12/2003	EP1361222A1 Sidechain-bearing taxanes
11/11/2003	US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003	US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/06/2003	WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003	WO2003091417A2 Self-similar ordered microstructural arrays of amphiphilic molecules
11/06/2003	WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003	WO2003091395A2 Inhibition of immune complex formation
11/06/2003	WO2003091391A2 Atherosclerotic phenotype determinative genes and methods for using the same
11/06/2003	WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003	WO2002083854A9 Antibodies to vla-1
11/06/2003	US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003	US20030207327 Eukaryotic cells engineered to differ by as few as one encoded amino acid at a defined target locus; for therapeutic and pharmacogenic use
11/06/2003	CA2483337A1 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003	CA2483007A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/05/2003	EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003	EP0699073B1 xenogeneic transplantation
11/05/2003	EP0489837B1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
10/2003
10/30/2003	WO2003089625A2 Product
10/30/2003	WO2003089609A2 Short fragment homologous replacement to provide bse resistant cattle
10/30/2003	WO2003089590A2 TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
10/30/2003	US20030204050 Comprises polypeptide for treating arthritis, cancer, autoimmune, kidney and inflammatory disorders
10/29/2003	EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003	EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003	CN1452659A Corynebacterium glutamicum genes encoding metabolic pathway proteins
10/29/2003	CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/23/2003	WO2003087371A1 Antiviral therapy on the basis of rna interference
10/23/2003	WO2003087339A2 Spray freeze dry of compositions for pulmonary administration
10/23/2003	WO2003087328A2 Method of generating non-naturally occuring protein models
10/23/2003	WO2003087321A2 Plant acyl-coa synthetases
10/23/2003	WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003	WO2003050242A3 Dna amplification and sequencing using dna molecules generated by random fragmentation
10/23/2003	WO2003040319A3 Endothelial cells derived from primate embryonic stem cells
10/23/2003	WO2002097061A3 Iterative promoter affinity chromatography to identify trans-regulatory networks of gene expression
10/23/2003	WO2002077197A3 Methods for diagnosing and monitoring malignancies by screening gene copy numbers
10/23/2003	WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003	US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003	US20030198988 Optimization of crossover points for directed evolution
10/23/2003	CA2482438A1 Plant acyl-coa synthetases
10/23/2003	CA2482395A1 Antiviral therapy on the basis of rna interference
10/22/2003	CN1125174C Recombinant phages
10/16/2003	WO2003085096A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003	US20030195337 UL16 binding protein 4
10/16/2003	US20030195157 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
10/16/2003	US20030194720 Human ion channels
10/16/2003	CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/15/2003	EP1352960A1 Antiviral therapy on the basis of RNA interference
10/15/2003	EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003	EP1352056A2 Polypeptides
10/15/2003	CN1449440A Masp-2, a complement-fixing enzyme, and uses for it
10/14/2003	US6632673 Mutation results in substitution in gene; genetic engineering
10/14/2003	US6632426 G-CSF analog compositions and methods
10/09/2003	WO2003083086A2 High level expression of immunogenic proteins in the plastids of higher plants
10/09/2003	WO2003083065A2 Improved methods for achieving expression from alphavirus vectors
10/09/2003	WO2003083046A2 Novel proteins and nucleic acids encoding same
10/09/2003	WO2003048325A3 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
10/09/2003	US20030190748 In the presence of fibroblast growth factor; allows stable prolifertion and differentiation while maintaining karyotype
10/09/2003	US20030190309 Novel probiotics for pet food applications
10/08/2003	EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/02/2003	WO2003080826A1 Saccharomyces cerevisiae yeast strain with improved phytase activity
10/02/2003	WO2003080805A2 Kinases and phosphatases
10/02/2003	US20030186873 DNA sequences that codes for biological receptors involved in signal transduction, used for prophylaxis of inflammation and immunology related diseases and/or disorders
10/02/2003	US20030186443 Phytase active yeast
10/02/2003	US20030186343 Immunoglobulin which binds low density lipoprotein receptor for diagnosis, prevention or treatment of viral infections; viricides
10/02/2003	US20030186324 Sensory neuron receptors
10/02/2003	US20030186288 Universal RT-coupled PCR method for the specific amplification of mRNA
10/02/2003	CA2517582A1 Saccharomyces cerevisiae yeast strain with improved phytase activity
10/01/2003	CN1445361A Gordona nitida and application of removing sulfur element from sulfur compound
10/01/2003	CN1122719C Modified biological material
10/01/2003	CN1122716C Extracorporeal ceel culture and transplantation kits
09/2003
09/30/2003	US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/25/2003	WO2003078625A2 An improved method for synthesising templated molecules
09/25/2003	WO2003078603A2 Strong gene sets for glioma classification
09/25/2003	WO2003078589A2 Method of identifying genes controlling diferentiation
09/25/2003	WO2003078583A2 Optimization of crossover points for directed evolution
09/25/2003	WO2003078570A2 Multiple controls for molecular genetic analyses
09/25/2003	WO2003040295A3 Ion channel
09/25/2003	US20030180769 Forming 8 polynucleotide products differentially labeled with 8 characteristic fluorophores comprise a set, and identifying each of the eight polynucleotide products by a fluorescence or absorption spectrum analysis
09/25/2003	CA2518626A1 An improved method for synthesising templated molecules
09/25/2003	CA2478986A1 Method of identifying genes controlling differentiation
09/25/2003	CA2455607A1 Multiple controls for molecular genetic analyses
09/24/2003	CN1444647A Novel probiotics for pet. food applications
09/18/2003	WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003	WO2003076585A2 Controlled modulation of amino acid side chain length of peptide antigens
09/18/2003	WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
09/18/2003	US20030176647 Antibodies to OCIF-binding molecules
09/18/2003	US20030175850 Devices and methods for isolating target cells
09/18/2003	CA2478510A1 Genomic screen for epigenetically silenced tumor suppressor genes
09/17/2003	CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/16/2003	CA2119463C Glial cell line-derived neutrophic factor
09/12/2003	WO2003074658A2 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
09/12/2003	WO2003046133A3 Regulatory nucleic acid assay for diagnostic and library screens
09/12/2003	WO2003006612A3 Production of transduced hematopoietic progenitor cells
09/12/2003	CA2478022A1 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data
09/11/2003	US20030171904 Crystals and structures of ATP phosphoribosyltransferase
09/11/2003	US20030171878 Methods for the identification of genetic features for complex genetics classifiers
09/11/2003	US20030171559 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein
09/11/2003	US20030170689 Determination of nucleic acid sequence pattern
09/11/2003	US20030170675 Methods of manipulating nucleic acids
09/04/2003	WO2003072747A2 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) UTILIZING TOPOMERIC ALIGNMENT OF MOLECULAR FRAGMENTS
09/04/2003	WO2003072709A2 Variant tat proteins and methods for use thereof

1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 100